Adial Pharmaceuticals, Inc. (ADIL) vs Theriva Biologics, Inc. (TOVX)

Adial Pharmaceuticals, Inc. and Theriva Biologics, Inc. are both Biotechnology companies. Adial Pharmaceuticals, Inc. and Theriva Biologics, Inc. are of similar size ($11.3M and $10.6M). Adial Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Theriva Biologics, Inc. trades at 0.2×. Across the 9 metrics below, Adial Pharmaceuticals, Inc. leads on 5 and Theriva Biologics, Inc. on 4.

Valuation

Metric ADIL TOVX Biotechnology median
P/E n/m 0.16 7.88
P/S n/m n/m 11.47
P/B n/m 0.83 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.16 n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (379.24%) 642.32% (28.84%)
Free cash flow yield (56.08%) (126.58%) (23.03%)

Profitability

Metric ADIL TOVX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 352.60% (115.11%) (57.72%)
Return on assets (322.10%) (37.14%) (49.22%)
Return on invested capital 0.00% (301.72%) 0.00%

Growth

Metric ADIL TOVX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 82.46% 89.07% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADIL TOVX Biotechnology median
Debt to equity 0.00 0.13 0.00
Current ratio 5.63 1.13 4.73
Net debt to EBITDA 0.75 0.48 0.96

Dividend

Metric ADIL TOVX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ADIL TOVX Biotechnology median
Market cap 11.33m 10.58m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack